TLDR Dutasteride effectively treats hair loss and prostate issues.
This review paper provides an in-depth analysis of Dutasteride, a 5-alpha reductase inhibitor, highlighting its mechanism of action in reducing dihydrotestosterone (DHT) levels by inhibiting both types I and II enzymes. It examines Dutasteride's efficacy in treating androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH), noting improvements in symptom relief, urinary flow, and prostate size. The review also discusses its potential in combination therapy with alpha-blockers, its investigational role in prostate cancer prevention, and emerging applications in transgender medicine. The paper aims to inform healthcare professionals about Dutasteride's pharmacology and clinical applications.
3 citations
,
January 2001 in “Cambridge University Press eBooks” Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.
408 citations
,
May 2004 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism” Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.
21 citations
,
March 2018 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” 5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.
May 2024 in “Journal of clinical medicine” Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.
1 citations
,
July 2017 in “The Journal of Urology” Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.
13 citations
,
June 2018 in “Current Urology Reports” Hair loss drugs may cause sexual issues and infertility in men.